DAY ONE BIOPHARMACEUTICALS INC. - COMMON STOCK

Day One Announces Upcoming Presentations at 2022 Society for Neuro-Oncology Annual Meeting

11 Nov 2022 06:00:00 By Nasdaq GlobeNewswire

Day One Reports Third Quarter 2022 Financial Results and Corporate Progress

07 Nov 2022 15:30:00 By Nasdaq GlobeNewswire

Day One Announces Cooperative Research and Development Agreement with National Cancer Institute to Expand Development of Tovorafenib (DAY101)

17 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

Day One Appoints Garry Nicholson as Chairman of the Board of Directors

12 Sep 2022 07:30:00 By Nasdaq GlobeNewswire

Day One Reports Second Quarter 2022 Financial Results and Corporate Progress

04 Aug 2022 15:30:00 By Nasdaq GlobeNewswire

Day One to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference

02 Aug 2022 07:00:01 By Nasdaq GlobeNewswire

Day One Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

21 Jun 2022 07:30:00 By Nasdaq GlobeNewswire

Day One Announces Pricing of Upsized Public Offering of Common Stock

14 Jun 2022 19:00:00 By Nasdaq GlobeNewswire

Day One Announces Proposed Public Offering of Common Stock

14 Jun 2022 06:30:00 By Nasdaq GlobeNewswire

Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma

12 Jun 2022 16:00:00 By Nasdaq GlobeNewswire

Day One Announces First Patients Dosed in Phase 1b/2 Combination Study with Tovorafenib (DAY101) and Pimasertib in RAF-altered Solid Tumors

23 May 2022 07:30:00 By Nasdaq GlobeNewswire

Day One Reports First Quarter 2022 Financial Results and Provides Business Update

12 May 2022 15:30:00 By Nasdaq GlobeNewswire

Day One to Present at the 21st Annual Needham Virtual Healthcare Conference

06 Apr 2022 07:30:00 By Nasdaq GlobeNewswire

Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress

07 Mar 2022 06:30:00 By Nasdaq GlobeNewswire

Day One to Participate in the Cowen 42nd Annual Health Care Conference

28 Feb 2022 15:05:02 By Nasdaq GlobeNewswire

Day One to Present at the 40th Annual J.P. Morgan Healthcare Conference

05 Jan 2022 07:00:02 By Nasdaq GlobeNewswire

Day One Announces First Patient Dosed in Phase 2 Monotherapy Study in RAF-altered Solid Tumors

22 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

Day One to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

18 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

Day One Reports Third Quarter 2021 Financial Results and Corporate Progress

08 Nov 2021 15:50:00 By Nasdaq GlobeNewswire

Day One Announces Presentation at 2021 Connective Tissue Oncology Society (CTOS) Virtual Annual Meeting

03 Nov 2021 07:00:02 By Nasdaq GlobeNewswire